News
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants ...
Late-night snacks can support weight loss—what matters most is choosing balanced, nutrient-dense options. A top pick is ...
Kylie Kelce Makes Surprising Admission About Jason Kelce's Weight Loss Journey originally appeared on Parade. Kylie Kelce ...
By Andrew Silver SHANGHAI (Reuters) -Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its ...
Keeping Up With the Kardashians' star Khloé Kardashian has been open about her health journey over the years. Here's ...
Dr. Mahsa Tehrani discusses how patients use medication to help them lose weight on 'America Reports.' ...
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback